Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

GV20 Oncotherapy Completes Series B Financing to Advance Pipeline into the Clinic and Expand Immuno-Oncology Drug Discovery Platform

prnasiaOctober 18, 2021

Tag: GV20 Oncotherapy , Coatue , Immuno-Oncology

PharmaSources Customer Service